Exploring The Hormonal Route. Hair=life.

Zœy

Member
My Regimen
Reaction score
44
It's a shame Janester isn't still around they could answer your horse pee queries, I believe they took this for quite some time.
I'd seek bioidentical, but if conjugated is all that's available where you are it might force your hand. There is an increased blood clot risk (as others have already mentioned) I'm not sure if this can be mitigated by supplementing with aspirin? I've never tried it tbf (which is surprising, I've tried everything)

Can you not order from outside of your country from one of the HRT.Cafe sites?
 

Zœy

Member
My Regimen
Reaction score
44
Diane35 is just Ethinylestradiol and Cyproterone acetate you should be fine with that one (blood clot risk again tho)

I had a good result when taking diane.

I've more recently tried a birth control that had levonorgestrel instead of CPA and that did make my hair fall out. Some kind of conflict with finasteride.
 

finastride23

Member
My Regimen
Reaction score
5
Diane35 is just Ethinylestradiol and Cyproterone acetate you should be fine with that one (blood clot risk again tho)

I had a good result when taking diane.

I've more recently tried a birth control that had levonorgestrel instead of CPA and that did make my hair fall out. Some kind of conflict with finasteride.
did you experience shed at first when you start diane?
 

Zœy

Member
My Regimen
Reaction score
44
I personally didn't shed on diane, I had about 2.5 years after starting HRT where my hair grew strong and didn't shed at all. Nothing on the brush it was amazing.

I'm now going through a massive shed period (last few months) but this is unrelated and probably shock loss from recent surgery
 

Solxama

Banned
My Regimen
Reaction score
306
I think what's left of my bald spot, the worst part right on the top of the crown to be precise, has started going through a shed. I just washed my hair and noticed loads of hair on my hands when I went over it.

But together with my overall progress I take it as a good thing, it means the old and weak hair is making room for new, stronger hair.
 

Almas_NW0

Senior Member
My Regimen
Reaction score
1,540
1632417242514.png
 

Derelict

Senior Member
My Regimen
Reaction score
1,311
Just started regularly taking progynova, couldn't take meds for a bit, only on 1mg though, i will give it 3 months or something and see if i notice any change, if not i might increase to 2mg.
 

MylovelyHair

Established Member
My Regimen
Reaction score
223
What is the defference between Estradiol hemihydrate usually on topical gel and Estradiol Valerate?? Is it the same what is the best for hair thinning thickenning oral or topical no injectiions?
 

Get my hair back

Established Member
My Regimen
Reaction score
60
Valerate and semihydrate (E2) are bioidentical estrogens, well tolerated and accepted by the body and have fewer side effects than ethinyl estradiol (EE).
I've taken both drugs, and if I had to choose, I'd prefer the half-hydrate - its molecular weight is less and it's more suitable for sublingual administration.
I've never taken EE and I don't recommend that crap to anyone.
 

Experimentality

Established Member
My Regimen
Reaction score
224
Dug up some cool research on prolactin (PRL) and its effects on scalp hair loss.

Calcineurin upregulates PRL receptor expression in human HFs

We already knew that our old friend Cyclosporine A inhibits calcineurin, and thereby potently upregulates stem cell (SC) differentiation. From the article:

One key regulator of SC activity in the HF is the transcription factor nuclear factor of activated T cells c1 (Nfatc1), which is expressed in bulge SCs (Tumbar et al. 2004; Rhee et al. 2006; Horsley et al. 2008). Nfatc1 activity is directly regulated by the phosphatase calcineurin (CN), which dephosphorylates Nfatc1 to induce its nuclear translocation and transcriptional activity (Rao et al. 1997; Horsley and Pavlath 2002). Inactivation of Nfatc1 through skin-specific genetic knockout or treatment with cyclosporine A (CSA), an inhibitor of CN (Mattila et al. 1990), results in precocious activation of HF growth in mice (Paus et al. 1989; Gafter-Gvili et al. 2003; Horsley et al. 2008).
Then, the study continues to identify a previously unknown relation to prolactin:
In this study, we identified genetic changes associated with SC activation following administration of CSA, a robust activator of follicular SCs. Gene expression profiling revealed a novel molecular interplay between Nfatc1 and Prlr, implicating Prl signaling as a regulator of SC activity in the hair. Using pharmacological and genetic experiments in mice, we revealed that Prl signaling and Nfatc1 expression are required for the abrogation of hair growth during pregnancy. Furthermore, we demonstrated that direct administration of Prl promotes HF quiescence. Finally, we showed that Prl signaling activates Jak/Stat5 signaling in follicular SCs to maintain their dormancy. Our findings unveil a novel CN–Nfatc1–Prlr–Stat5 pathway that governs skin SC quiescence downstream from a systemic hormone.
In simpler terms, calcineurin is at the start of this CN-Nfatc1-PRL-Stat5 axis. Thus, CN upregulates PRL receptor density, whereas Cyclosporine A directly kills the entire pathway. So far, CsA is the only compound that I ran across that directly downregulates PRL receptors. The study also continues to show that PRL, and by extension Stat5 induces "SC quiescence", which is the same as shortening anagen/inducing catagen in HFs (which we already knew). More on the catagen inducing effects of PRL can be read here, among others.

More studies then. Bad news for E2 (and thyrotropin).

E2 increases PRL secretion and PRL receptor density in HFs

Oestrogen treatment significantly upregulated PRL and PRLR immunoreactivity in selected skin and hair follicle compartments, at the gene and protein level (P < 0.05).
This was at concentrations of 100nM, which can be achieved by a 1mcg/mL E2 topical. It is unknown what concentrations are achieved with oral/transdermal full HRT, because serum concentrations do not necessarily correspond to scalp concentrations. Of course, the positive effects of E2 will (massively) override the negative effects it has on PRL secretion (as shown in other papers mentioned in other posts of mine), but still it is something to be aware of. PRL should ideally be reduced (and receptors be blocked to prevent upregulation).

In conclusion, PRL receptor density is downregulated by CsA, but it is not a PRL receptor antagonist (so far, only the experimental antibody is). CsA increases SC differentiation and promotes anagen. It is unknown if other CN inhibitors like Tacrolimus can promote anagen to a similar extent as CsA, but they should all be able to potently downregulate PRL receptor density. Safety concerns aside, this makes them interesting compounds to consider for topical hairloss formulations (apart from its PRLr downregulating effect, CsA also inhibits sFRP1 (inducing the Wnt pathway) and inhibits several interleukins (ILs), thereby directly increasing SC differentiation and suppressing inflammitory responses).
 
Last edited:
Top